United States · FDA National Drug Code directory
Nabumetone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50228-465_2b9b03ef-e03c-eca1-e063-6394a90a3fad
- Product NDC
- 50228-465
- Form
- TABLET
- Composition / generic term
- Nabumetone
- Labeler
- ScieGen Pharmaceuticals Inc
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190626
- Source listing expiry
- 20261231
Source-listed ingredients
- NABUMETONE — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (50228-465-01) · 50228-465-01
- 500 TABLET in 1 BOTTLE (50228-465-05) · 50228-465-05
- 30 TABLET in 1 BOTTLE (50228-465-30) · 50228-465-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →